Dr. Priya Bhosale | Clinical Trials | Best Researcher Award
Professor of radiology at MD Anderson Cancer Center | United States
Dr. Priya Bhosale is a distinguished Professor of Diagnostic Radiology at The University of Texas MD Anderson Cancer Center, specializing in abdominal and gynecologic imaging. With a career marked by academic excellence, clinical leadership, and pioneering research, she has significantly advanced imaging techniques for cancer diagnosis and treatment planning. She has held numerous leadership roles, contributed to international cancer care guidelines, and mentored emerging medical professionals. Renowned for her dedication to innovation and quality improvement, Dr. Bhosale actively participates in professional societies, editorial boards, and multidisciplinary initiatives, striving to enhance patient care, radiology practice standards, and global collaboration in oncologic imaging.
Publication Profile
Google Scholar
Education
Dr. Priya Bhosale earned her MD in Medicine from D.Y. Patil Medical College, Kolhapur, India, followed by advanced radiology training at the University of Pennsylvania and a fellowship at MD Anderson Cancer Center. She has pursued multiple leadership, innovation, and management programs at prestigious institutions including MD Anderson, the American College of Radiology, Association of University Radiologists, and Rice University. Her academic credentials also include an MBA in Health Care Management and Corporate Strategy. These diverse educational experiences have equipped her with expertise in clinical excellence, leadership development, strategic planning, quality control, corporate innovation, and emotional intelligence, all applied to medical practice.
Experience
Dr. Priya Bhosale has served at MD Anderson Cancer Center progressing from Assistant Professor to Professor in Diagnostic Radiology. She holds concurrent appointments at UT Health Science Center in Houston. She has directed numerous programs including the Quantitative Imaging Core, chaired key quality committees, and led gynecologic imaging initiatives. Beyond academic roles, she has contributed to national and international cancer committees, served as course director, and collaborated in multidisciplinary research. Her leadership spans peer review committees, strategic planning groups, and educational programs, impacting both institutional and global radiology practices through innovation, quality improvement, and patient-centered imaging advancements.
Awards & Honors
Dr. Priya Bhosale has been recognized through competitive leadership program nominations, including the MD Anderson Leadership Institute and the Radiology Leadership Institute. She has been entrusted with chairing influential national committees such as those in the Society for Advanced Body Imaging and the Texas Radiological Society. Her selection for prestigious executive education at Rice University underscores her leadership stature. She has served as an invited moderator, panelist, and presiding officer at leading radiology and oncology conferences, highlighting her expertise and influence. Through her work, she has advanced imaging research, quality standards, and multidisciplinary collaboration, earning respect across academic, clinical, and research communities.
Research Focus
Dr. Priya Bhosale research centers on advanced abdominal and gynecologic cancer imaging, with an emphasis on MRI applications, quantitative imaging, and multi-modality diagnostic strategies. She develops and evaluates imaging biomarkers to improve cancer detection, staging, treatment planning, and response assessment. Her work integrates radiology with pathology and oncology to refine precision medicine approaches. She also investigates quality improvement in imaging protocols and reproducibility in multi-center trials. As an active member of national cancer steering committees and working groups, she contributes to shaping imaging guidelines, fostering innovation, and translating research into practice to enhance outcomes for patients with complex oncologic diseases.
Publication Top Notes
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis
Ovarian cancer, the revised FIGO staging system, and the role of imaging
Predictors and patterns of recurrence after definitive chemoradiation for anal cancer
The inguinal canal: anatomy and imaging features of common and uncommon masses
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Imaging of pancreatic adenocarcinoma: update on staging/resectability
Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25-year single-institution experience
Cervical cancer: 2018 revised international federation of gynecology and obstetrics staging system and the role of imaging
Imaging and staging of endometrial cancer
Chemotherapy induced liver abnormalities: an imaging perspective
Imaging features of carcinoid tumors of the gastrointestinal tract